Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C2671
http://purl.obolibrary.org/obo/NCIT_C2671
|
|---|---|
| Preferred Name | MMP Inhibitor S-3304 |
| Definitions |
An orally-agent agent with potential antineoplastic activity. S-3304 inhibits matrix metalloproteinases (MMPs), thereby inducing extracellular matrix degradation, and inhibiting angiogenesis, tumor growth and invasion, and metastasis. (NCI04)
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | An orally-agent agent with potential antineoplastic activity. S-3304 inhibits matrix metalloproteinases (MMPs), thereby inducing extracellular matrix degradation, and inhibiting angiogenesis, tumor growth and invasion, and metastasis. (NCI04) |
|---|---|
| prefLabel | MMP Inhibitor S-3304
|
| label | MMP Inhibitor S-3304
|
| PDQ_Closed_Trial_Search_ID | 38596
|
| code | C2671
|
| prefixIRI | NCIT:C2671
|
| in_subset | |
| Preferred_Name | MMP Inhibitor S-3304
|
| FDA_UNII_Code | BK459F050X
|
| Contributing_Source | FDA
|
| Maps_To | MMP Inhibitor S-3304
|
| CAS_Registry | 203640-27-1
|
| NCI_Drug_Dictionary_ID | 38596
|
| Legacy Concept Name | S-3304
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 38596
|
| Semantic_Type | Pharmacologic Substance
|
| UMLS_CUI | C1134613
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |